Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and
survival in patients with breast cancer, and accurate assessment of axillary LN involvement …

Identifying the presence of axillary node and internal mammary node metastases in patients
with invasive breast cancer is critical for determining prognosis and for deciding on …

Importance Recent data from clinical trials have challenged traditional thinking about axillary
surgery in patients with breast cancer. Objectives To summarize evidence regarding the role …

Background Axillary nodal status is the most important prognostic factor for patients with
breast cancer. Clinical assessment and imaging modalities are not always reliable. Surgical …

Sentinel lymph node biopsy (SLNB) is widely employed to detect axillary lymph node
metastases in breast cancer patients with clinically negative (N0) axillae. One of the few …

Background Axillary staging in patients with breast cancer and clinically node-negative
disease is performed by sentinel node biopsy (SLNB). The aim of this study was to integrate …

Axillary lymph node dissection (ALND) is associated with significant morbidity, whilst
sentinel node biopsy (SNB) has the potential to minimize complications in the management …

Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in clinically
node-negative (cN0) breast cancer patients without neoadjuvant chemotherapy (NAC). The …

The axillary nodal status is accepted universally as the most powerful prognostic tool
available for early stage breast cancer. The removal of level I and level II lymph nodes at …

Axillary lymph node status, a major prognostic factor in early-stage breast cancer, provides
information important for individualized surgical treatment. Because imaging techniques …